NCT00076310 2026-04-15OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting50 enrolled 11 charts
NCT00705016 2014-04-30ADVANTAGEMerck KGaA, Darmstadt, GermanyPhase 1/2 Completed184 enrolled 20 charts
NCT00401401 2011-12-23Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck CancerGenmabPhase 1/2 Terminated30 enrolled 13 charts
NCT00229723 2009-08-04IRESSAâ„¢ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell CarcinomaAstraZenecaPhase 2 Completed224 enrolled 21 charts